Consistent with our findings, one study showed that an elevated level of EZH2 was associated with over proliferation of tumor cells and worse prognosis and may have clinical utility for distinguishing indolent PRAD from aggressive disease with a fatal course (31). The gene discussed is EZH2; the disease is neoplasm.